McKesson (MCK) Declines After Issuing Soft Second Quarter EPS Guidance

McKesson (NYSE: MCK) disclosed:

McKesson Corporation participated in the Wells Fargo 2024 Healthcare Conference on September 5, 2024, as previously noticed in the company’s August 7, 2024 earnings release and on its investor relations website investor.mckesson.com.

During the conference webcast, McKesson affirmed fiscal 2025 full year Adjusted Earnings per Diluted Share guidance in the range of $31.75 to $32.55. McKesson also indicated it anticipates second quarter fiscal 2025 Adjusted earnings per Diluted Share to be in the range of $6.70 to $7.00.

(Consensus sees Q2 EPS of 7.39 and FY EPS of 32.21)

You May Also Be Interested In

• Taiwan Semi (TSM) PT Raised to $554; Bernstein SocGen: 'Recent pullback presents a good entry point'
• Protara Therapeutics, Inc. (TARA) Misses Q2 EPS by 2c
• RadNet (RDNT) PT Raised to $94 at Truist Securities